FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 700 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Having Cancer as a Young Adult Put Me on a Path... May 25, 2021 FDA Granted Accelerated Approval to Belantamab Mafodotin-blmf for Multiple Myeloma August 14, 2020 Three Brothers Under The Age Of 6 Are All Fighting The... February 7, 2020 Cancer and the Holidays December 3, 2021 Load more HOT NEWS New Treatment Helps Survivors Regain Sensation After Breast Cancer FDA Grants Accelerated Approval to Lurbinectedin for Metastatic SCLC EMA Recommends Granting a Marketing Authorisation for Tisotumab Vedotin Substantial Clinical Activity of Teclistamab in Patients with Heavily Pretreated Relapsed...
